Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Study to Investigate Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily in Subjects With Papulopustular Rosacea

NCT01025635 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT01025635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01025635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Study to Investigate Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily in Subjects With Papulopustular Rosacea
Lead sponsor
LEO Pharma
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2009
Completion date
August 31, 2010
Enrollment
401 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

papulopustular rosacea